Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Endo Int'l Plc (ENDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,604,489
  • Shares Outstanding, K 224,404
  • Annual Sales, $ 2,947 M
  • Annual Income, $ -1,031,470 K
  • 60-Month Beta 1.17
  • Price/Sales 0.54
  • Price/Cash Flow 1.13
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.45
  • Number of Estimates 8
  • High Estimate 0.66
  • Low Estimate 0.36
  • Prior Year 0.67
  • Growth Rate Est. (year over year) -32.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.87 +7.42%
on 04/22/19
9.10 -18.90%
on 03/26/19
-0.95 (-11.40%)
since 03/22/19
3-Month
6.87 +7.42%
on 04/22/19
12.49 -40.91%
on 02/28/19
-2.08 (-21.99%)
since 01/23/19
52-Week
5.41 +36.29%
on 05/04/18
18.50 -60.11%
on 10/17/18
+1.86 (+33.70%)
since 04/23/18

Most Recent Stories

More News
Endo to Announce First-Quarter 2019 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2019 financial results on May 9, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a.m....

ENDP : 7.38 (+3.22%)
Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's PROVENTIL® (albuterol sulfate)...

ENDP : 7.38 (+3.22%)
MRK : 74.60 (+1.55%)
Why Is Endo (ENDP) Down 26.9% Since Last Earnings Report?

Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ENDP : 7.38 (+3.22%)
Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes

Endo International plc (the "Company" or "Endo") today announced the early tender results of the previously announced cash tender offers (the "Tender Offers") made by Endo Finance LLC ("Endo Finance"),...

ENDP : 7.38 (+3.22%)
Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes

Endo International plc (NASDAQ: ENDP) (the "Company" or "Endo") today announced the early tender results of the previously announced cash tender offers (the "Tender Offers") made by Endo Finance LLC ("Endo...

ENDP : 7.38 (+3.22%)
Medical Device Industry Revenues Should Outpace Healthcare Field

The U.S. markets are bullish on the future of the medical device markets. In addition to projections that postulate that: "In 2024, the total medical technology revenue globally is expected be nearly $600...

ALDX : 8.20 (+6.36%)
MHMNF : 54.5000 (unch)
ENDP : 7.38 (+3.22%)
ABBV : 78.66 (+0.65%)
BPTH : 18.05 (unch)
SOLY : 13.72 (+11.64%)
Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse

Catalyst (CPRX) reports wider-than-expected loss in the fourth quarter of 2018.

CELG : 93.67 (+0.27%)
ENDP : 7.38 (+3.22%)
BDSI : 4.89 (+5.84%)
CPRX : 5.40 (+0.19%)
Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Leading Peer-Reviewed Dermatology Journal Features Phase 2 Data

ENDP : 7.38 (+3.22%)
BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up

BioDelivery Sciences (BDSI) reports in-line loss in Q4. Sales beat the consensus mark. The company issues encouraging guidance for 2019.

ENDP : 7.38 (+3.22%)
CI : 153.82 (+3.94%)
BDSI : 4.89 (+5.84%)
TEVA : 14.91 (+1.43%)
Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes

Endo International plc ("Endo") today announced that Par Pharmaceutical, Inc. (the "Issuer"), its wholly-owned subsidiary, priced $1.5 billion aggregate principal amount of 7.500% senior secured notes...

ENDP : 7.38 (+3.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ENDP with:

Business Summary

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova,...

See More

Key Turning Points

2nd Resistance Point 7.75
1st Resistance Point 7.56
Last Price 7.38
1st Support Level 7.08
2nd Support Level 6.79

See More

52-Week High 18.50
Fibonacci 61.8% 13.50
Fibonacci 50% 11.96
Fibonacci 38.2% 10.41
Last Price 7.38
52-Week Low 5.41

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar